Novel heterocyclic compounds
CA 2289001 A1 · Owner: Jakobsen, Palle · Inventors: Jakobsen, Palle; Kristiansen, Marit; Lundbeck, Jane Marie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel piperidine compounds are provided and those compounds are useful in the treatment and/or prevention of diabetes and especially non-insulin dependent , diabetes (NIDDM or type 2 diabetes) including overnight or meal treatment and treatment or prevention of long-term complications such as retinopathy, neuropathy, nephropathy and micro- and macro-angiopathy; treatment of hyperglycemia, hypercholesterolemia, hypertension hyperinsulinemia, hyperlipidemia, atherosclerosis or myocardial ischemia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 6, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 6, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 6, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.